2017
Amphetamine-related drugs neurotoxicity in humans and in experimental animals: Main mechanisms
MORATALLA, Rosario; Amit Suresh KHAIRNAR; Nicola SIMOLA; Noelia GRANADO; Jose Ruben GARCIA-MONTES et al.Základní údaje
Originální název
Amphetamine-related drugs neurotoxicity in humans and in experimental animals: Main mechanisms
Autoři
MORATALLA, Rosario; Amit Suresh KHAIRNAR; Nicola SIMOLA; Noelia GRANADO; Jose Ruben GARCIA-MONTES; Pier Francesca PORCEDDU; Yousef TIZABI; Giulia COSTA a Micaela MORELLI
Vydání
PROGRESS IN NEUROBIOLOGY, OXFORD, PERGAMON-ELSEVIER SCIENCE LTD, 2017, 0301-0082
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30103 Neurosciences
Stát vydavatele
Velká Británie a Severní Irsko
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 14.163
Označené pro přenos do RIV
Ano
Kód RIV
RIV/00216224:14740/17:00097313
Organizační jednotka
Středoevropský technologický institut
UT WoS
EID Scopus
Klíčová slova anglicky
Dopamine; Ecstasy; Methamphetamine; METH; MDMA; Mouse; Neurodegeneration; Neuroinflammation neurotoxicity; Non-human primate; Rat
Štítky
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 16. 5. 2018 10:50, Mgr. Pavla Foltynová, Ph.D.
Anotace
V originále
Amphetamine-related drugs, such as 3,4-methylenedioxymethamphetamine (MDMA) and methamphetamine (METH), are popular recreational psychostimulants. Several preclinical studies have demonstrated that, besides having the potential for abuse, amphetamine-related drugs may also elicit neurotoxic and neuroinflammatory effects. The neurotoxic potentials of MDMA and METH to dopaminergic and serotonergic neurons have been clearly demonstrated in both rodents and nonhuman primates. This review summarizes the species-specific cellular and molecular mechanisms involved in MDMA and METH-mediated neurotoxic and neuroinflammatory effects, along with the most important behavioral changes elicited by these substances in experimental animals and humans. Emphasis is placed on the neuropsychological and neurological consequences associated with the neuronal damage. Moreover, we point out the gap in our knowledge and the need for developing appropriate therapeutic strategies to manage the neurological problems associated with amphetamine-related drug abuse. (C) 2015 Elsevier Ltd. All rights reserved.